#Listening is this year's theme for #WorldKidneyCancerDay. CRISPR Therapeutics is committed to listening to and learning from people who live with #KidneyCancer. Meet Chuck, an incredible advocate who is living with #RenalCellCarcinoma. Read his inspiring story here: https://bit.ly/3UxwO3n
CRISPR Therapeutics’ Post
More Relevant Posts
-
Imagine what you could do with 40% more cells after every isolation… Make it a reality with Akadeum's Alerion Microbubble Cell Separation System and our Human T Cell Leukopak Isolation Kit. Find out how Poseida Therapeutics is benefitting from the Alerion in this Case Study: https://hubs.li/Q02FVWDc0 #morecells #akadeum #celltherapy #cellisolation
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> John Carroll on his cancer diagnosis; #ESMO's biggest surprise; Lykos' bad trip; Rate cuts, and more >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #productmarketing #healthcare #pharmaceutical
To view or add a comment, sign in
-
Thoughts on this? >> John Carroll on his cancer diagnosis; #ESMO's biggest surprise; Lykos' bad trip; Rate cuts, and more >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #productmarketing #healthcare #pharmaceutical #pharma
John Carroll on his cancer diagnosis; #ESMO's biggest surprise; Lykos' bad trip; Rate cuts, and more
endpts.com
To view or add a comment, sign in
-
Introducing "Our Stories," a dedicated page that showcases who we are as a company—think of it like a blog, but even better. Here, you'll find compelling narratives about how we make a positive impact on health. From insightful features on our work in biopharma, oncology, and distribution to articles spotlighting the meaningful contributions of our company and employees in fulfilling our mission, "Our Stories" encapsulates it all. Dive into these inspiring stories here: https://lnkd.in/gcE99MYe
Our Stories is our page dedicated to highlighting who we are as a company – much like a blog, but better. These stories encompass the many ways we positively impact health, from interesting features about our work in areas like biopharma, oncology and distribution to articles that spotlight the impactful work our company and our employees are doing to fulfill our mission. Read the stories here: https://lnkd.in/g6S33Ruq
Our Stories
To view or add a comment, sign in
-
CEO of Axol Bioscience, enabling “Better Human Disease Models” with iPSC technology in neurodegenerative disease
Huntington’s Disease Researchers Check out the Axol poster demonstrating Characterization of striatal neurons derived from >140 CAG iPSCs for Huntington’s Disease modeling. Helping to build better human disease models #neuroscience #research #drugdevelopment #pharma #biopharma #geneediting #biotechnology #lifesciences #pharmaservices #biotechnologyresearch #cellandgenetherapy #humancells #ipsc #stemcells
Interested in Huntington's Disease research and drug discovery? Click below to download our poster! Following on from the 19th Annual Huntington's Disease Therapeutics Conference, we've made our poster on advanced in vitro Huntington's Disease models available to download. You can explore the data behind our work using iPSC technology to build more human-relevant models of Huntington's Disease for research and drug discovery. Click here to download our poster "Characterization of striatal neurons derived from >140 CAG iPSCs for Huntington’s Disease modeling": https://hubs.la/Q02p7gSM0 If you have any questions or would like to discuss a project, please get in contact at operations@axolbio.com #iPSCs #CHDI #HuntingtonsDisease #StemCells #DrugDiscovery
To view or add a comment, sign in
-
Founder Director @ Mestastop | Metastasis Research, Drug Discovery, Repurposing & Predictive Diagnostics
The clinical data and details are available on the website; Technologies>Case Studies>Lymph node status is not a good marker for metastasis probability; why? https://lnkd.in/gatzMypY
We are the metastasis specialists.. Read this 👇 case study to. .. to know how we are striving to fight cancer metastasis by providingbest-in-class solutions for drug discovery, drug repurposing and clinical translation. Click the link below to request a copy of the original research data of this case study https://lnkd.in/gjJRvvCY #metastasis #drugdesign #drugmanufacturing #pharmaceuticalindustry #pharmaceuticalmanufacturing #clinicaltrials #clinicalpharmacy
To view or add a comment, sign in
-
Join our very own Clinical Supply Manager, Danielle L. Hagen, as she shares valuable insights at this week's 3rd BioPharma Supply Chain & Logistics Nexus. Don’t miss out on learning about the intricacies and innovations in personalized cancer vaccine supply chains. See you there! #BioPharmaNexusConference #BioPharma #SupplyChain
To view or add a comment, sign in
-
Interested in Huntington's Disease research and drug discovery? Click below to download our poster! Following on from the 19th Annual Huntington's Disease Therapeutics Conference, we've made our poster on advanced in vitro Huntington's Disease models available to download. You can explore the data behind our work using iPSC technology to build more human-relevant models of Huntington's Disease for research and drug discovery. Click here to download our poster "Characterization of striatal neurons derived from >140 CAG iPSCs for Huntington’s Disease modeling": https://hubs.la/Q02p7kv20 If you have any questions or would like to discuss a project, please get in contact at operations@axolbio.com #iPSCs #CHDI #HuntingtonsDisease #StemCells #DrugDiscovery
To view or add a comment, sign in
-
Sr. Talent Sourcing Partner ♦ McKesson (a Fortune 9 company) ♦ Corporate Talent Finder in Healthcare ♦ Certified Diversity Recruiter
Advancing health outcomes for ALL
Our Stories is our page dedicated to highlighting who we are as a company – much like a blog, but better. These stories encompass the many ways we positively impact health, from interesting features about our work in areas like biopharma, oncology and distribution to articles that spotlight the impactful work our company and our employees are doing to fulfill our mission. Read the stories here: https://lnkd.in/g6S33Ruq
Our Stories
To view or add a comment, sign in
-
After successfully completing Phase II clinical trials for their medication to treat Major Depressive Disorder, ABVC BioPharma Inc (NASDAQ:ABVC). and AiBtl Biopharma Inc. are now embarking on a groundbreaking clinical study focused on Depression in Cancer Patients. This new study will integrate AI-driven solutions to address the significant challenge of depression among cancer patients, a condition that often complicates treatment and adversely affects overall quality of life. Watch at #Proactive #ProactiveInvestors http://ow.ly/eUgT105B3q5
ABVC BioPharma's CEO Discusses New Drug Development and AI Integration
proactiveinvestors.com
To view or add a comment, sign in
96,727 followers